<DOC>
	<DOCNO>NCT00549341</DOCNO>
	<brief_summary>The safety efficacy Mentor Purified Toxin , Botulinum Toxin Type A , Purified Neurotoxin , inject intramuscularly neck , evaluate treatment painful non-painful spasmodic torticollis/cervical dystonia . It hypothesize treatment decrease symptom severity significant side effect .</brief_summary>
	<brief_title>PurTox ( Botulinum Toxin Type A ) Treatment Adult Onset Spasmodic Torticollis/Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Diagnosis torticollis noticeable symptom least 6 month Total TWSTRS score great equal 20 , TWSTRS severity score great equal 10 TWSTRS Disability score great equal 3 ( must meet 3 criterion ) Diagnosis isolate anterocollis Concurrent myopathic disease , myotonic dystrophy ( form muscular dystrophy ) , myasthenia gravis Currently receive aminoglycoside antibiotic therapy , curarelike drug , quinidine , succinylcholine , polymixins , anticholinesterase , magnesium sulfate , lincosamides Any illness consider Investigator make subject inappropriate candidate Cervical spine injury within 18 month head neck surgery within 6 month prior screen Preexisting dysphagia History active autoimmune disease Exposure botulinum toxin base pharmaceutical within 3 month prior screen History primary nonresponse secondary resistance prior exposure botulinum base pharmaceutical History chemotherapy/radiation malignant disease within 24 month Any investigational drug/device 30 day prior screen</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Torticollis</keyword>
	<keyword>Cervical Dystonia</keyword>
</DOC>